Clinical trial
Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver
NCT00323414 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00323414 |
|---|---|
| Title | Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver |
| Official title | Randomized Controlled Trial of Omega-3 Fatty Acids in the Treatment of Non-Alcoholic Steatohepatitis in Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fatty Liver |
| Intervention type | Drug |
| Interventions | Polyunsaturated fatty acid (Opti-EPA), Placebo |
| Enrollment | 37 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | May 9, 2006 |
| Last update posted | Feb 23, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: